福安药业: 2025年半年度业绩预告

Group 1 - The company expects a net profit of 100 million to 130 million yuan for the current reporting period, a decrease of 39.95% to 53.81% compared to the same period last year, where the net profit was 216.48 million yuan [1] - The expected net profit after deducting non-recurring gains and losses is estimated to be between 91 million and 121 million yuan, reflecting a decline of 40.50% to 55.25% from the previous year's 203.37 million yuan [1] - The primary reason for the decline in performance is attributed to significant price reductions in the company's main products due to the nationwide implementation of centralized procurement, leading to decreased revenue and profit margins [1] Group 2 - The impact of non-recurring gains and losses on net profit is estimated to be around 9 million yuan, mainly from government subsidies received [1]